Robert Blum - Lytham Partners
Gary Winzenread - Chief Operating Officer and Senior Vice President of Product Development & Strategy
Robert Watson - Chief Executive Officer, President and Director
Stephen Murdock - Chief Financial Officer
Joseph Mondillo - Sidoti & Company, LLC
Sam Rebotsky - SER Asset Management
Streamline Health Solutions (STRM) Q1 2011 Earnings Call June 7, 2011 4:30 PM ET
Good afternoon, and welcome to the Streamline Health Solutions Reports First Quarter 2011 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Mr. Robert Blum. Mr. Blum, please go ahead.
Thank you, Amy. And thank you for joining us today to review the financial results of Streamline Health Solutions for the first quarter of fiscal year 2011, which ended April 30, 2011. As the conference call operator indicated, my name is Robert Blum. I am with Lytham Partners. We are the investor relations consulting firm for Streamline Health.
With us on the call representing the company today are Bob Watson, President and Chief Executive Officer; Steve Murdock, Chief Financial Officer; Gary Winzenread, Senior Vice President and Chief Operating Officer; and Rick Leach, Senior Vice President and Chief Marketing Officer. At the conclusion of today’s prepared remarks, we will open the call for a question-and-answer session. If anyone participating on today’s call does not have a full text copy of the release, you can retrieve it from the company’s website at www.streamlinehealth.net or numerous financial websites.
Before we begin with prepared remarks, we submit, for the record, the following statement. Statements made by the management team of Streamline Health Solutions during the course of this conference call that are not historical facts are considered to be forward-looking statements subject to risks and uncertainties.
The Private Securities Litigation Reform Act of 1995 provides a Safe Harbor for such forward-looking statements. The words believe, expect, anticipate, estimate, will and other similar statements of expectation identify forward-looking statements. The forward-looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein.
These risks and uncertainties include, but are not limited to, the impact of competitive products and pricing; product demand and market acceptance; new product development; key strategic alliances with vendors that resell the company's products; the ability of the company to control costs; availability of products produced from third-party vendors; the healthcare regulatory environment; healthcare information systems budgets; availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems; fluctuations in operating results; and other risks detailed from time to time in the Streamline Health Solutions' filings with the U.S. Securities and Exchange Commission.
Participants on this call are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
With that said, let me turn the call over to Bob Watson, President and Chief Executive Officer of Streamline Health Solutions. Bob?
Thank you, Robert, and good afternoon to all of you participating in today's call. Thank you for your time today and for your continued interest and support of the company.
I indicated to you, on the previous quarter's call, that immediately upon joining Streamline Health, I engaged in a thorough review of the solutions, the operations and the personnel of the company. With the benefit of an entire quarter under my belt, I am fully convinced that Streamline Health has a solid portfolio of solutions and services that will support healthcare organizations in driving operational and financial efficiencies and that our solutions assist healthcare organizations in meeting the requirements of meaningful use. As we discussed before, meeting these requirements helps to make our clients eligible for significant incentive payments as outlined in the HITECH Act.
After visiting or talking with many of our clients, I've discovered they share my beliefs that Streamline Health offers a strong value proposition that provides significant cost efficiencies, given our deep and meaningful integration with EMR vendors such as GE, Cerner, Allscripts, MEDITECH and Epic.
From a solutions positioning standpoint, we have a clear and leverageable advantage in the marketplace, given the depth of our integration work. I've also discovered that our clients highly value the operational and technical support that our associates provide, and many of them have come to view us as a true partner who works to see them be successful.
Our legacy as a Health Information Management-oriented company has successfully differentiated us from other vendors who entered the healthcare vertical from another industry focus. The importance of this legacy became evident last quarter when we saw 2 clients resist internal IT department pressure to change to a new document management system that was bundled into the deployment of a new electronic medical record system within their respective facilities. These clients stayed with Streamline Health's best-of-breed solution set rather than settling for a single-source IT product that had fewer capabilities and less functionality.
In the just-concluded quarter, we have taken the necessary steps to optimize our sales results and right-side the infrastructure of the company to reflect the current revenue profile of the business and to give us the flexibility to adapt as the business grows.
As you can see from today's press release, meaningful progress has been achieved, but this is a process that will take us several quarters to fully realize the benefits. We believe that, in the coming quarters, our more efficient operating cost structure will play out in meaningful reductions in our spend patterns that will have a positive impact on our bottom line results.
At this point, I'd like to turn the call over to Steve Murdock, our Chief Financial Officer, for a summary of our financial results for the quarter. As you know, Steve joined us recently and brings 25 years of financial experience in the healthcare vertical. I look forward to his leadership and financial guidance in the coming years.
At the conclusion of Steve's remarks, I'll provide additional perspective on the results of the quarter, and then we'll open the call for your questions. Steve?
Thanks, Bob. I'd like to highlight the more significant aspects of the financial results for our first quarter ended April 30, 2011. Total revenues for the 3 months ended April 30, 2011, were $4.1 million compared to $3.5 million in the comparable quarter of 2010, an increase of 17%. Professional services revenue increased 53% or $348,000 over the prior comparable first quarter, primarily as a result of meeting milestones on system implementations and services sold in prior quarters.
Recurring revenue from maintenance contracts increased $192,000 or 10% over the prior comparable first quarter as a result of revenue recognized from backlog and from commencement of maintenance periods subsequent to the first quarter of 2010. Additionally, recurring revenue from software- as-a-service increased $75,000 or 9% over the prior comparable quarter as a result of achieving go-live status for one large client subscription sold in 2010.
Total operating expenses for the 3 months ended April 30, 2011, were $4.4 million compared to $4.7 million in the comparable quarter of 2010, a decrease of 6%. The decrease is primarily a result of decrease in capitalized software amortization as older components of previously capitalized software became fully amortized subsequent to the first quarter of 2010, and cost-saving measures implemented to reduce infrastructure cost.
The overall decrease was somewhat offset by increases in stock-based compensation, allowance for doubtful accounts and accruals for severance costs. The cost of systems sales for the first quarter was $548,000, a 27% decrease over the prior comparable quarter. The decline was primarily a result of the decrease in amortization of software -- of capitalized software, as previously mentioned.
The cost of services, maintenance and support was $1,334,000, as compared to $1,382,000 for the prior comparable quarter, a 3% decrease as a result of staff reductions in implementation services, BPM consulting and reductions in the costs of third-party maintenance contracts. The cost of software-as-a-service was $436,000 compared to $457,000 for the prior comparable period. The decrease is a result of renegotiation of third-party license and maintenance agreements, which were offset by an increase in depreciation on infrastructure as a result of growth in hosting center operations.
Selling, general and administrative expenses for the first quarter were $1,665,000 as compared to $1,698,000 for the prior comparable quarter. Decreases in salaries, commissions and professional fees were offset by an increase in stock-based compensation relating to the new management team, allowance for doubtful accounts and severance cost.
Research and development expenses for the first quarter were $418,000 compared to $470,000 for the prior comparable quarter, a decrease of 11%. When examining total research and development expenditures, capitalized software development costs must also be considered. The company capitalized 787 -- excuse me, $785,000 in software development costs for the first quarter as compared to $696,000 for the prior comparable quarter. Therefore, total research and development expenditures for the first quarter were $1,203,000 or a 3% increase over research and development expenditures of $1,166,000 for the prior comparable quarter.
The company incurred an operating loss for the quarter ended April 30, 2011, of $254,000 as compared to an operating loss of $1,201,000 for the prior comparable quarter. The $947,000 decrease in the operating loss is a result of the items previously discussed. As a result, the company incurred a net loss for the first quarter ended April 30, 2011, of $281,000 or $0.03 per share compared to a net loss of $1.2 million or $0.13 per share in the first quarter of 2010.
New bookings for the first quarter, primarily consisting of professional services and third-party hardware and software, was $791,000. Total backlog at the end of the quarter ended April 30, 2011, was $17.7 million compared to $18.6 million at April 30, 2010, and $17.6 million at January 31, 2011. The majority of the backlog is related to software-as-a-service and maintenance contracts, versus software licensing sales. First quarter software-as-a-service revenues are primarily generated from previously reported backlog.
In our earnings release, we have a table -- we have included a table reconciling our net loss to the non-GAAP financial measurement of adjusted EBITDA. We define adjusted EBITDA as net earnings or loss, plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets and stock-based compensation expense.
Given the relatively large amount of non-cash charges, we feel that adjusted EBITDA is a more meaningful measure in understanding our underlying cash-based earnings. For the 3 months ended April 30, 2011, adjusted EBITDA was $630,000 compared to a corresponding adjusted EBITDA of negative $225,000 for the prior comparable quarter. We will continue to provide this non-GAAP financial measure in future earnings releases.
Our cash balance at April 30, 2011, was approximately $482,000, with $1.5 million drawn on our line of credit. Our cash cycles are still very dependent on seasonal patterns of prepaid annual maintenance fees from our clients, and we will continue to use our availability on our line of credit to supplement our cash needs in those quarters where prepaid maintenance fees are not as substantial as other quarters.
We continue to monitor our expenses, cash balances and collections carefully to ensure that we remain on plan, and we believe that we have the appropriate capital resources available to operate our business, going forward.
That concludes my review of the financial results for the first quarter. Let me now turn the call back to Bob Watson. Bob?
Thanks, Steve. As related to the quarter, we are obviously pleased with the 17% increase in revenues versus last year's first quarter. Professional and maintenance services revenues increased 21% over Q1 2010, and recurring revenues from our software-as-a-service clients increased 9% relative to the same prior period.
Going forward, we believe that the recurring revenue of our software-as-a-service model will be a growth driver of this business. We will be dedicating a great deal of time, effort and resources to grow this critical component of the overall business. The retention rate of clients that engage Streamline Health through the software-as-a-service model is well over 90% because of the superior operational and financial results that our solutions will provide and the leading-edge service that we provide those clients. We offer a compelling value proposition that generates consistent results and high client satisfaction.
The primary goal is to position Streamline Health to consistently grow annual revenues at a 15% or greater annual rate and to grow adjusted EBITDA, less capitalized software, at an equal or greater rate year-over-year starting in 2012. However, we are pleased that, in our first full operating quarter of fiscal 2011, we achieved double-digit revenue gain and substantially reduced our operating costs.
On a non-GAAP basis, adjusted EBITDA, less capitalized software, was a negative $155,000 for this quarter compared to a negative $921,000 in the prior year quarter. While the nature of our revenue will feature some lumpiness due to product mix and the natural variability of hospital IT purchase patterns, we believe we are off to a good start in fiscal 2011, and we expect that EBITDA in the second half of the year will more fully reflect the expense reductions initiated in the just-completed quarter.
We continue to anticipate that revenue for fiscal 2011 will be down slightly from 2010. This is reflective of our retailing of the sales processes and the shifting of certain sales opportunities away from the traditional license sale model to the software-as-a-service model, which reduces recognized revenue in the near term in exchange for long-term revenue stability. This strategy is central to our operating expansion plan.
During my last call, I introduced you to 5 strategic areas of focus that I believe will help us transform our business. Those points included: becoming a market-facing organization; building a sales and distribution network to assure that Streamline Health is aware of and is actively working to secure every new healthcare information technology opportunity that falls within the scope of the capabilities of our solutions set; leveraging our core competencies to broaden the scope of our Solutions portfolio and expanding our recurring revenue stream within our client base; and fourth, building the human capital required to accomplish the foregoing; and fifth, and most importantly, continuing to drive costs out of our infrastructure. I'd like to take a moment and give you an update on our progress on those areas.
First, we are building a complete understanding of the needs of our current clients specifically, and of the overall market place, in general. We are rapidly transforming into an externally facing organization. As mentioned on the last call, we have aligned all of our externally facing functions: business development, sales, account management, marketing and product management into one area under our Chief Marketing Officer, Rick Leach.
One of the top priorities for our team is to personally connect with each of our clients. It may sound very basic, but as we have discovered during numerous client visits this quarter, many of our clients have felt neglected over the past several years, and they're very happy to have reconnected with the Streamline Health team. Their feedback and insights into our solutions and services have been invaluable. We have assigned an account manager to have primary responsibility for the success, satisfaction and retention of each and every account. Again, this is a basic and fundamental business process that had simply not been done in the past. By aligning our externally facing functions under one executive, we are already experiencing positive results.
Second, we are actively working to secure every new opportunity that falls within the scope of the capabilities of our solutions set. An indicator of the positive movement in this area is the recruitment of an experienced senior sales executive and the realignment of responsibilities across the entire sales organization.
You likely have seen the press release about Gabriel Waters recently joining us as Vice President of Business Development and Western Region Sales Executive. Working with Rick Leach, Gabe has already opened up discussions with several potential new channel partners both domestically and internationally and has accelerated several sales opportunities that were stalled in the sales pipeline.
We're also leveraging Gabe's experience to assist our account managers in closing sales to existing clients. This coupling of an experienced healthcare IT sales executive with an account manager is a change in the previous Streamline Health sales model. We believe it will help us grow our revenue from our existing client base in an accelerated timeframe.
Third, we are leveraging our core competencies to broaden the scope of our product portfolio and expand our recurring revenue stream within our client base. We believe that there is a significant opportunity to migrate more of our licensed clients to our software-as-a-service model, which will result in, as we discussed earlier in this call, a stable and predictable recurring revenue stream for the company.
For example, subsequent to the end of Q1, but prior to this call, we closed one such deal with a client in the Northeast valued at $1.2 million over 7 years. And we have several similar transactions in the sales funnel.
It's worth noting that there are several factors that contribute to this trend. First and foremost, clients are challenged to manage the ever-expanding workload caused by the impact of their implementation of electronic medical record systems so they can capture the previously noted federal stimulus funds. Second, many are planning to upgrade to our newest releases, which will give them access to new, meaningful use and ICD-10 capabilities contained in those releases.
Third, by migrating to our data center, they don't have to acquire managed hardware and third-party software associated with self-hosting our applications. Rick and his team have identified a number of current clients who are strong candidates for this migration strategy and are actively engaged in moving those opportunities through our sales pipeline.
Finally, in the same strategic area, we have identified clients who are candidates for new workflows, both standard and custom. An example of this is an agreement we just executed with a current client in New York City for our Coding Workflow product that is valued at nearly $250,000.
With this other current client and understanding our workflow offering, we recently conducted a webinar for those identified clients. The webinar featured 2 clients that have our workflows in operation as co-presenters. They were able to explain the value their organizations derive from the custom workflow solutions developed by Streamline Health. These incremental revenue opportunities can add up and help us roll -- round out our sales results.
Fourth, we are bringing together the human capital that's required to accomplish the other 4 areas of strategic focus as we transform to a world class healthcare IT company. The recent additions of Steve Murdock, our CFO; Rick Leach, our Chief Marketing Officer; and Gabe Waters, as our VP of Business Development, underscore our commitment to bring the company -- bring into the company highly experienced and successful health care executives and associates. We continue to be very selective when adding new associates for our organization. We will, as I discussed in the previous call, seek new associates that have had a successful, demonstrable career in a growth-oriented health care IT company.
It is important to note that, after 4 months of working with the current pool of associates at Streamline, that this group, which has, by the way, an average tenure of nearly 10 years, have demonstrated their adaptability and capabilities and will, as you would expect, have a material and positive impact as we move forward.
In recognizing that contribution, one key part of our culture change at Streamline Health was to recognize the value of all of our associates by extending our stock option program to include every single associate. We believe that this will ensure that they feel and, most importantly, act, like owners and stakeholders in the company's success.
In addition, we renewed an employee stock purchase program that allows our associates to purchase stock via payroll deductions. Nearly 30% of the eligible associates have elected this voluntary stock purchase plan.
Fifth, we are driving cost out of our infrastructure. During the quarter, we eliminated a significant number of positions that were either not being fully utilized or no longer in line with our strategic plan for 2011 and beyond. While painful in the short term, this clearly will make us stronger in the long term. Combined with the implementation of a new sales automation system and a robust sales and operations management system, we will be more efficient. Additionally, Steve Murdock has identified a number of administrative and financial areas where efficiency will be increased through automation.
Finally, we are selectively moving some capabilities to outsourced resources. This process of moving certain quality assurance and development projects that are ideally suited for outsourcing to an outsource mode will allow us to develop our solutions in a quicker, more nimble and, over time, less-expensive mode. Gary Winzenread, our Chief Operating Officer, is leading this initiative. We have already migrated a significant portion of our quality assurance functions to outsourced resources.
In summary, I'm pleased with the progress we made during the first quarter in each of our 5 strategic areas of focus. However, I do want to remind everyone that this is, in the words of Erik Spoelstra, the coach of NBA's Miami Heat, a process. By the very definition of the word process, this will take time, but we will transform Streamline Health. I want to thank our entire team of associates for their hard work, results and willingness to accept each of our steps in the process. We have plenty to do to reach our goal of becoming a world class healthcare IT company, but the progress made to date has given this management team and our fellow associates the confidence that we're moving in the right direction.
This concludes my prepared remarks. We'll now open the call for your questions. In addition to Steve and myself, we will be joined in this QA session by Gary Winzenread and Rick Leach. [Operator Instructions]
[Operator Instructions] Our first question is from Joe Mondillo with Sidoti & Company.
Joseph Mondillo - Sidoti & Company, LLC
I was wondering, you touched a little bit about the hospital IT purchase pattern. Could you give us a little bit more color on what you're seeing in the industry right now?
Now, one of the trends that's a result of the sort of push to meaningful use and the attempt to get the stimulus dollars is that the IT departments are overwhelmed. So a couple of things happen when they get overwhelmed. It tends to slow down their purchasing of things not directly related to the core EMR. So now our advantage in that kind of environment is our ability to shift people to the software-as-a-service model. But the primary impact is just the departments are overloaded with demands being placed on them as they roll out the EMRs. And I think I mentioned this on the last call, I think we're in the position that the second phase of the advanced directives part of the HITECH Act is really where our solutions come into play. So I think we're adequately positioned but there's just some variability in timing in the purchases.
Joseph Mondillo - Sidoti & Company, LLC
Okay. And I just have one other question. How much is the credit revolver, currently?
Joseph Mondillo - Sidoti & Company, LLC
$3 million. And in your opinion, how much cash do you need to run the -- to fully fund the business?
I mean, our current line of credit and our history of 65% or so of our revenues being recurring, I think we're in a perfectly fine position to run the business as we run it today. I think we're in good shape. And the answer to your question is -- simple answer is, I think we're in a good shape on the cash side so...
[Operator Instructions] The next question is from Mark Cahill, [ph] a private investor.
When do you expect to be done with the bulk of your hiring? I understand you always look for new talent, but when do you expect to be done with the bulk?
Yes, we do have a sense of urgency around it. I mean, for the most part, I think we're -- by the end of this quarter, early Q3 at the outside, we'll -- I think we'll be done with our -- any significant hiring. But we're -- one thing we've put in place by putting in place someone who's actually in the role of human capital. I think we're continually looking to improve our mix of talented resources and associates. So again, it's all part of the process, but the bulk of the hiring, by the end of the second quarter, early third quarter, is finished.
Okay, and I understand that there's always kind of a lag when you hire someone, they've got to get educated on the way the company's run, the products, et cetera. When do you think these new hires, particularly the sales and marketing side, will do -- when will they be ready to run rather than walk?
Well, we -- Rick and I sort of look at this as we're in a -- that there are 4 phases to this: one being a crawl, one being the walk, the jog and then the run. And I think we're past the crawling part of it. We're certainly in the walk phase. We're still recruiting for an East Coast Sales Exec. Once we have that position filled, which we're planning to fill in Q2, I'd say we will enter the jog phase. It should take that sales executive a quarter or so to get up to speed. And one comment on that. The reason why we can get them up to speed that quickly is that we've been very, very deliberate about trying to fill this position. There's a very, very specific profile, and we could have filled the position earlier and chose to wait it out to make sure we had the exact right candidate. So if that person comes on in Q2, they're up to full speed at the end of Q3. By Q4, we're in the run phase. And if you go back to the call in April, this year was about positioning ourselves for what we're going to deliver in 2012. So we'll be running at full tilt in Q4, towards 2012.
I noticed Mr. Waters has a dual responsibility: business development and sales and marketing. Does he report to Rick? How does that all work?
All of those client -- external market-facing roles report to Rick. And that's -- Gabe does have a dual role, but again, it's -- as you know, in the business development side of things, that they have peaks and wanes and valleys in the way in which they -- those types of conversations occur over time. Having Gabe also responsible for direct sales activity in the West allows us to better leverage his time.
Right. I noticed in your comments that he's already got ideas, and that's just ideas for international prospects and partners. Do you think he'll stick mostly with U.S. and a little bit of international presence?
Of course. Don't misinterpret that comment. We are not going to lose focus on our 2011 plan. We are committed to a plan, we're staying on that plan. Now that being said, given the fact that Gabe and others of us on the team have experience in markets outside of North America, we will opportunistically respond to those opportunities. And that -- is it a key, central part of our strategy for 2011? It is not. But we will devote some energy to it when it's appropriate.
Good. I noticed in your -- some of your operating comments, you talked about migrating existing clients to the software-as-a-service model. In the past, some of these clients, they paid upfront in the license model. Are you talking about those types of clients, getting them to the SaaS model?
Yes. We have a certain portfolio of clients that are currently paying us maintenance that are on older versions of the product. Part of our sales strategy as we take them down the migration path to upgrade to either 1.9 or 5.1, when it's available, is to put forth a plan that says, "Rather than going on a maintenance agreement with us, outsource it to us in our software-as-a-service model and use our data center." And that's quite attractive to them. It takes out the costs of them having to acquire and support third-party hardware and software. It reduces their own internal IT resources devoted to the project because that burden falls to us. We had one customer, as we just noted, just make that switch in the last couple of weeks. So that's a model that I think, for Streamline, is very, very, very good opportunity for us to grow our recurring revenue base in an accelerated fashion.
Okay, good. In the last call, you had mentioned GE and their change in their -- kind of a policy change in their marketing. They're not going to go after new customers. And I think you said that they were still devoted to current customers. Let's see, I saw a recent article that kind of negated that comment, so I just wanted to get clarification here. It sounds to me like, and I think you said this in the last conference call, GE is still pursuing sales to current customers.
I knew somebody was going to ask me the GE question, Mark. I think it's going to come up every call. So the answer is -- the deal that we were just talking about, where the client shifted from maintenance to our software-as-a-service model, was actually a GE client. There are opportunities in the current GE installed base. We do know -- I mean, the facts are that GE's Centricity platform has been pummeled by the folks at Epic and that they are losing some market share to Epic. That's a fact. We do know that GE's customers are having challenges getting up to meaningful use, and there is an internal focus on that at GE this year. That being said, like I said in the last call, there are opportunities for us to sell into the current installed GE base.
Right, okay. Two other questions. In your opening comments, you had mention a new 7-year deal. Was that after the quarter ended?
That was after the quarter ended. That was what we were just talking about -- it was some of the key.
All right. And one last question now regarding meaningful use. I've read articles that other companies, HIT companies have brought out products. Yes, they're technically meaningful products but the usability of these products is in question, yet. If it takes 10 minutes to download something, it's aggravating. Do you reckon the others hear comments like this about usability versus meaningful use?
Well, the reality is, yes, we do hear those kind of -- I mean, there is always a question of usability and user satisfaction. We think, for example, that one of our leverageable core competencies in that regard is that, because our integration with EMR vendors is so deep, complete, it puts us in a position that for our clients, where they have the opportunity to use us as part of their meaningful use strategy, we can give them a solution that doesn't impact their performance. They're a very key part of this, so -- but we do hear it. I mean, there are challenges. I mean, anybody who's installing an EMR in any facility of any size -- I mean, I don't care whether you're a 100-bed hospital or a -- 1,000-bed hospital, the business process change that comes with it is material. Along with that, there are functionality challenges in some of the products. And I just -- but we've tried to focus on -- again, historically, Streamline has done a very, very good job at this. And under various guidance and leadership for the last 3 years on the operations side of our business, I think we've been very, very mindful of the usability of our product and its performance under pressure. We're looking forward, obviously, to getting the 5. x product into the U.S. market, which I think, will further improve not only our integration, but our performance and user friendliness. I think those are all key parts of the strategy here that we're going to continue to not lose sight of.
Are you trying to emphasize quality and get your class ratings up at the KLAS ratings?
Yes. I mean, all of us in the business have to. It's sort of one the lesser evils. You have to live with it, and we're going to focus on it. I mean, I think, in the past that, historically, the organization hasn't been as friendly towards the rating agency, if you will. And so I think there are things that we can do with our customers and with the rating agencies to help them understand why a best-of-breed product like this has value, has relevancy and is a better option for a healthcare provider than a product. I mean, one of the things we try to -- as we think about product positioning here, that were talking about it, but we're positioning our solutions versus a product. The 2 clients that were being polled by IT to try to get them to switch out to a product tied back in the management solution and they decided to stay with us, is a perfect example of why we're relevant and why we're relevant in the long term. And that's the -- I don't think that's a conversation, a message that's been clearly articulated, historically. And we will articulate that better with our customers so they understand when they get called by KLAS how to answer the question. And we'll also tell the story to marketplace that way, so our new prospects will understand why this is important. There is a place for a best-of-breed solution in this space.
Right, now, that sounds good. One last clean-up question. There was 2 add-on deals announced in the fourth quarter. Were those add-on deals to a hosted agreement or to an upfront license agreement, do you know?
They were not software-as-a-service. They were add-up -- one was an upgrade, and the other was an add-on to an existing license agreement.
They get implemented in 2011, do you think?
Yes, both of them.
One is already.
One of them is already, and Gary just said one of them is already up.
[Operator Instructions] And our next question comes from Sam Rebotsky with SER Asset Management.
Sam Rebotsky - SER Asset Management
When we -- this particular quarter, the loss was significantly less, and you indicated that the next quarter, the significant part of the improved profitability should be in the second half. How should we look at your performance as far as -- should we look at significant contracts that are taking place, that you're getting, that you're announcing? Should we look for any dollar amount of contracts to sort of when you will achieve profitability? And with visibility going forward, how should we look at this?
Yes, I think there's a couple of key things to note here. One, because we're focused on the shift of existing licensed customers to the software-as-a-service model, and that we have gone back to people in the sales pipeline that were originally looking at a licensed sale and have moved them towards the idea of moving to the software-as-a-service model -- yes, a couple of things happen. Near-term, that's going to affect near-term revenue recognition, but will put us in a position going into 2012, '13, '14, '15 where the predictability of our revenue will be quite solid. So I'm judging our performance as I look at the number of deals and transactions that we do where we've created a long-term, stable revenue stream.
Sam Rebotsky - SER Asset Management
Yes, that sounds good. Well, good luck in achieving your stable revenue stream, and hopefully, that there will be more recognition, I guess, when they see you accomplish this.
It's -- we're telling the story against what we're executing on. Yes, we think there is a tremendous opportunity to do this. We've shown some early returns, which are quite positive in that regard. It creates an opportunity for us to move our recurring revenue number from 65-or-so-percent last year up to -- it ought to be a significant number of percentage points higher that -- than that as we get out beyond 2012, 2013. And it does a couple things. It also, in addition to the stabilizing the revenue, removing the lumpiness from it, it also creates a degree of stickiness with our customer base that the cost of separation becomes exceedingly high.
Sam Rebotsky - SER Asset Management
There's no doubt that these contracts keep getting additional contracts with the revenue -- the visibility of revenue going forward within your time. It should create the profitability, which is where -- which is what I'm looking forward to and, frankly, increasing the size of the revenue, in addition, because they create a profitability should you cover your fixed costs, and that should be good. So that's what I'm looking forward to, your achieving.
This concludes our question-and-answer session. I would like to turn the conference back over to Mr. Watson for any closing remarks.
Again, my thanks, everyone, for participating on today's call. In the past quarter, we have taken some initial steps in implementing what we believe is a solid, strategic plan. We have brought on board some of the critical team members to get us where we want to go, and we firmly believe that we can and will achieve our goals in building an innovative, healthcare IT solutions provider that can grow consistently and profitably and drive enhanced shareholder value. We have a lot to look forward to. I look forward to talking to you again at the conclusion of the next quarter. Thank you. Have a good evening.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect your telephone line.
Copyright policy: All transcripts on this site are the copyright of Seeking Alpha. However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet. (Until now investors have had to pay thousands of dollars in subscription fees for transcripts.) So our reproduction policy is as follows: You may quote up to 400 words of any transcript on the condition that you attribute the transcript to Seeking Alpha and either link to the original transcript or to www.SeekingAlpha.com. All other use is prohibited.
THE INFORMATION CONTAINED HERE IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY'S CONFERENCE CALL, CONFERENCE PRESENTATION OR OTHER AUDIO PRESENTATION, AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE AUDIO PRESENTATIONS. IN NO WAY DOES SEEKING ALPHA ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY'S AUDIO PRESENTATION ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.
If you have any additional questions about our online transcripts, please contact us at: email@example.com. Thank you!